Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type (1 selected)

Type

Guidance programme

Showing 1401 to 1450 of 2013

Published guidance, NICE advice and quality standards
TitleReference numberPublishedLast updated
Dementia, disability and frailty in later life – mid-life approaches to delay or prevent onsetNG16
Procalcitonin testing for diagnosing and monitoring sepsis (ADVIA Centaur BRAHMS PCT assay, BRAHMS PCT Sensitive Kryptor assay, Elecsys BRAHMS PCT assay, LIAISON BRAHMS PCT assay and VIDAS BRAHMS PCT assay)HTG386
Home care: delivering personal care and practical support to older people living in their own homesNG21
Coeliac disease: recognition, assessment and managementNG20
Vedolizumab for treating moderately to severely active Crohn's disease after prior therapyTA352
Bevacizumab for treating relapsed, platinum‑resistant epithelial ovarian, fallopian tube or primary peritoneal cancer (terminated appraisal)TA353
Edoxaban for treating and for preventing deep vein thrombosis and pulmonary embolismTA354
Transcranial direct current stimulation (tDCS) for depressionHTG382
Preoperative high dose rate brachytherapy for rectal cancerHTG383
Antimicrobial stewardship: systems and processes for effective antimicrobial medicine useNG15
Insertion of a double balloon catheter for induction of labour in pregnant women without previous caesarean sectionHTG380
Joint distraction for knee osteoarthritis without alignment correctionHTG381
Naloxegol for treating opioid‑induced constipationTA345
Aflibercept for treating diabetic macular oedemaTA346
Nintedanib for previously treated locally advanced, metastatic, or locally recurrent non‑small‑cell lung cancerTA347
Everolimus for preventing organ rejection in liver transplantationTA348
Secukinumab for treating moderate to severe plaque psoriasisTA350
Cangrelor for reducing atherothrombotic events in people undergoing percutaneous coronary intervention or awaiting surgery requiring interruption of anti‑platelet therapy (terminated appraisal)TA351
Insertion of an epiretinal prosthesis for retinitis pigmentosaHTG372
Radiofrequency ablation for gastric antral vascular ectasiaHTG373
Suture fixation of acute disruption of the distal tibiofibular syndesmosisHTG374
Ultrasound‑enhanced, catheter‑directed thrombolysis for deep vein thrombosisHTG375
Ultrasound‑enhanced, catheter‑directed thrombolysis for pulmonary embolismHTG376
Electrotherapy for the treatment of haemorrhoidsHTG377
Implantation of a sphenopalatine ganglion stimulation device for chronic cluster headacheHTG378
Omalizumab for previously treated chronic spontaneous urticariaTA339
Vedolizumab for treating moderately to severely active ulcerative colitisTA342
Apixaban for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolismTA341
Lower urinary tract symptoms in men: managementCG97
Obinutuzumab in combination with chlorambucil for untreated chronic lymphocytic leukaemiaTA343
Challenging behaviour and learning disabilities: prevention and interventions for people with learning disabilities whose behaviour challengesNG11
Violence and aggression: short-term management in mental health, health and community settingsNG10
Implantation of a left ventricular assist device for destination therapy in people ineligible for heart transplantationHTG369
Insertion of endobronchial nitinol coils to improve lung function in emphysemaHTG370
Implantation of a duodenal–jejunal bypass liner for managing type 2 diabetesHTG371
Rivaroxaban for preventing adverse outcomes after acute management of acute coronary syndromeTA335
Empagliflozin in combination therapy for treating type 2 diabetesTA336
Rifaximin for preventing episodes of overt hepatic encephalopathyTA337
Excess winter deaths and illness and the health risks associated with cold homesNG6
Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomesNG5
VibraTip for testing vibration perception to detect diabetic peripheral neuropathyHTG362
Safe midwifery staffing for maternity settingsNG4
Bladder cancer: diagnosis and managementNG2
Regorafenib for metastatic colorectal cancer after treatment for metastatic disease (terminated appraisal)TA334
Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional therapyTA329
Sofosbuvir for treating chronic hepatitis CTA330
Axitinib for treating advanced renal cell carcinoma after failure of prior systemic treatmentTA333
Flexible endoscopic treatment of a pharyngeal pouchHTG367
Eculizumab for treating atypical haemolytic uraemic syndromeHST1
Hysteroscopic metroplasty of a uterine septum for primary infertilityHTG363

Results per page

  1. 10
  2. 25
  3. 50
  4. All